Michael Kauffman, Chief Executive Officer at Karyopharm Therapeutics Inc. (KPTI), sold 15,000 shares at $19.53 ($289K) on 2020-07-09, disclosed to the SEC on 2020-07-13.
Open-market sale of $289k KPTI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.53 | 7,500 | $146K | 50.7% |
| 2 | $18.98 | 7,200 | $137K | 47.3% |
| 3 | $19.71 | 300 | $6K | 2.0% |
| Total | $19.27 avg | 15,000 | $289K | 100% |
| Filing → |
| KPTI | SELL | 2022-03-02 | $128K | — | Filing → |
| KPTI | SELL | 2022-02-22 | $440K | — | Filing → |
| KPTI | SELL | 2022-02-09 | $266K | — | Filing → |